ISO 10993-1:2025 Compliance & Biocompatibility - Eunoia Compliance<\/title>\r\n <style>\r\n \/* Eunoia Compliance Brand Palette *\/\r\n :root {\r\n --navy-blue: #002e5d;\r\n --brand-orange: #d35400;\r\n --text-dark: #333;\r\n --bg-light: #f4f7f9;\r\n }\r\n\r\n body {\r\n font-family: 'Helvetica Neue', Arial, sans-serif;\r\n line-height: 1.6;\r\n color: var(--text-dark);\r\n background-color: var(--bg-light);\r\n margin: 0;\r\n padding: 0;\r\n }\r\n\r\n .container {\r\n max-width: 900px;\r\n margin: 40px auto;\r\n background: #ffffff;\r\n padding: 50px;\r\n box-shadow: 0 10px 30px rgba(0,0,0,0.1);\r\n border-radius: 8px;\r\n }\r\n\r\n header {\r\n border-bottom: 3px solid var(--navy-blue);\r\n margin-bottom: 40px;\r\n padding-bottom: 20px;\r\n text-align: center;\r\n }\r\n\r\n .top-meta {\r\n font-size: 0.9em;\r\n letter-spacing: 1px;\r\n color: var(--navy-blue);\r\n font-weight: bold;\r\n margin-bottom: 10px;\r\n text-transform: uppercase;\r\n }\r\n\r\n h1 {\r\n color: var(--navy-blue);\r\n font-size: 2.5em;\r\n line-height: 1.2;\r\n margin: 10px 0;\r\n }\r\n\r\n .author-line {\r\n font-style: italic;\r\n color: #666;\r\n margin-bottom: 30px;\r\n }\r\n\r\n h2 {\r\n color: var(--navy-blue);\r\n font-size: 1.8em;\r\n border-left: 5px solid var(--brand-orange);\r\n padding-left: 15px;\r\n margin-top: 40px;\r\n }\r\n\r\n h3 {\r\n color: var(--brand-orange);\r\n font-size: 1.4em;\r\n }\r\n\r\n .highlight-quote {\r\n background: #f0f4f8;\r\n border-left: 5px solid var(--navy-blue);\r\n padding: 25px;\r\n font-size: 1.2em;\r\n font-style: italic;\r\n color: var(--navy-blue);\r\n margin: 30px 0;\r\n }\r\n\r\n table {\r\n width: 100%;\r\n border-collapse: collapse;\r\n margin: 25px 0;\r\n }\r\n\r\n th, td {\r\n border: 1px solid #dee2e6;\r\n padding: 15px;\r\n text-align: left;\r\n }\r\n\r\n th {\r\n background-color: var(--navy-blue);\r\n color: #ffffff;\r\n }\r\n\r\n tr:nth-child(even) { background-color: #f9f9f9; }\r\n\r\n .risk-high { color: #d9534f; font-weight: bold; }\r\n .risk-medium { color: #f0ad4e; font-weight: bold; }\r\n .risk-low { color: #5cb85c; font-weight: bold; }\r\n\r\n .author-bio {\r\n background: #eef2f6;\r\n padding: 30px;\r\n border-radius: 8px;\r\n margin-top: 60px;\r\n border: 1px solid #d1d9e6;\r\n }\r\n\r\n .cta-box {\r\n text-align: center;\r\n background: var(--navy-blue);\r\n color: white;\r\n padding: 40px;\r\n border-radius: 8px;\r\n margin-top: 40px;\r\n }\r\n\r\n .cta-button {\r\n display: inline-block;\r\n background: var(--brand-orange);\r\n color: white;\r\n padding: 15px 30px;\r\n text-decoration: none;\r\n border-radius: 5px;\r\n font-weight: bold;\r\n margin-top: 20px;\r\n }\r\n <\/style>\r\n<\/head>\r\n<body>\r\n\r\n<div class=\"container\">\r\n <header>\r\n <div class=\"top-meta\">PATIENT SAFETY | REGULATORY COMPLIANCE | ISO 10993<\/div>\r\n <h1>Is Your Device File Ready for 2025?<\/h1>\r\n <div class=\"author-line\">By Dr. Priyanka Murawala, PhD, DABT, Founder, Eunoia Compliance | 10 min read<\/div>\r\n <\/header>\r\n\r\n <section>\r\n <div class=\"highlight-quote\">\r\n \u201cThe era of checklist biocompatibility is closing. The era of defensible risk logic has begun.\u201d\r\n <\/div>\r\n <p>The sixth edition of <strong>ISO 10993-1<\/strong>, released in November 2025, redefines the entire framework for biological safety evaluation. It shifts the industry decisively away from prescriptive test selection toward scientifically justified, risk-based reasoning embedded within lifecycle risk management[cite: 94].<\/p>\r\n <\/section>\r\n\r\n <section>\r\n <h2>Key Components of Biocompatibility<\/h2>\r\n <p>Biocompatibility is the ability of a material to perform its intended function without eliciting a harmful local or systemic response in the patient[cite: 10]. Common biological hazards include:<\/p>\r\n <ul>\r\n <li><strong>Cytotoxicity:<\/strong> Cell death caused by toxic leachables[cite: 24].<\/li>\r\n <li><strong>Sensitization:<\/strong> Allergic responses triggered by chemical residues[cite: 25].<\/li>\r\n <li><strong>Genotoxicity:<\/strong> DNA damage that may increase cancer risk over time[cite: 26].<\/li>\r\n <li><strong>Hemocompatibility:<\/strong> Clotting or thrombosis in devices contacting the cardiovascular system[cite: 27].<\/li>\r\n <\/ul>\r\n <\/section>\r\n\r\n <section>\r\n <h2>Major Changes in ISO 10993-1:2025<\/h2>\r\n <table>\r\n <thead>\r\n <tr>\r\n <th>Change<\/th>\r\n <th>Impact<\/th>\r\n <\/tr>\r\n <\/thead>\r\n <tbody>\r\n <tr>\r\n <td>ISO 14971 Alignment<\/td>\r\n <td>Biological evaluation is now fully restructured around risk management.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>Revised Biological Effects<\/td>\r\n <td>\u201cEndpoints\u201d are now \u201cbiological effects,\u201d focusing on clinically relevant outcomes.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>Annex A Refocused<\/td>\r\n <td>Table A.1 is replaced by 4 tissue-specific tables within the main body.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>Local Effects Scope<\/td>\r\n <td>Broadened to recognize non-implantable devices may require tissue contact assessment.<\/td>\r\n <\/tr>\r\n <\/tbody>\r\n <\/table>\r\n <\/section>\r\n\r\n <section>\r\n <h2>Submission Risk Assessment<\/h2>\r\n <p>Inaction creates vulnerabilities during Notified Body review and FDA queries[cite: 109].<\/p>\r\n <table>\r\n <thead>\r\n <tr>\r\n <th>Situation<\/th>\r\n <th>Risk<\/th>\r\n <th>Action Required<\/th>\r\n <\/tr>\r\n <\/thead>\r\n <tbody>\r\n <tr>\r\n <td>Legacy devices (historical testing only)<\/td>\r\n <td class=\"risk-high\">HIGH<\/td>\r\n <td>Full gap assessment + updated scientific justification.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>EU MDR renewal cycle<\/td>\r\n <td class=\"risk-high\">HIGH<\/td>\r\n <td>BEP\/BER update to reflect 2025 structure.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>New FDA 510(k) submission<\/td>\r\n <td class=\"risk-medium\">MEDIUM<\/td>\r\n <td>Proactive gap analysis advisable.<\/td>\r\n <\/tr>\r\n <\/tbody>\r\n <\/table>\r\n <\/section>\r\n\r\n <div class=\"author-bio\">\r\n <h3>About the Author<\/h3>\r\n <p><strong>Dr. Priyanka Murawala, PhD, DABT<\/strong> is the founder of Eunoia Compliance and a board-certified toxicologist[cite: 114]. With over 10 years of experience, she has supported more than 50 product approvals across FDA, EU MDR, and global markets[cite: 114].<\/p>\r\n <\/div>\r\n\r\n <div class=\"cta-box\">\r\n <h3>Ready to Assess Your Gap?<\/h3>\r\n <p>Don\u2019t wait for a Notified Body query or FDA deficiency letter. Let\u2019s review your device files now and build a clear path to 2025 compliance[cite: 115].<\/p>\r\n <a href=\"mailto:pmurawala@eunoiacompliance.com\" class=\"cta-button\">Schedule a Free Consultation<\/a>\r\n <\/div>\r\n\r\n <footer style=\"text-align: center; font-size: 0.8em; margin-top: 40px; color: #999;\">\r\n \u00a9 2025 Eunoia Compliance \u00b7 Dr. Priyanka Murawala, PhD, DABT \u00b7 www.eunoiacompliance.com [cite: 116]\r\n <\/footer>\r\n<\/div>\r\n\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>ISO 10993-1:2025 Compliance & Biocompatibility – Eunoia Compliance PATIENT SAFETY | REGULATORY COMPLIANCE | ISO 10993 Is Your Device File Ready for 2025? By Dr. Priyanka Murawala, PhD, DABT, Founder, Eunoia Compliance | 10 min read \u201cThe era of checklist biocompatibility is closing. The era of defensible risk logic has begun.\u201d The sixth edition of … <a title=\"Is Your Device File Ready for 2025?\" class=\"read-more\" href=\"https:\/\/eunoiacompliance.com\/index.php\/2026\/05\/09\/is-your-device-file-ready-for-2025\/\" aria-label=\"Read more about Is Your Device File Ready for 2025?\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-756","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts\/756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/comments?post=756"}],"version-history":[{"count":4,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts\/756\/revisions"}],"predecessor-version":[{"id":760,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts\/756\/revisions\/760"}],"wp:attachment":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/media?parent=756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/categories?post=756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/tags?post=756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\n\t\t\t\t

\n\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\t\r\n\r\n\r\n \r\n \r\n ISO 10993-1:2025 Compliance & Biocompatibility - Eunoia Compliance<\/title>\r\n <style>\r\n \/* Eunoia Compliance Brand Palette *\/\r\n :root {\r\n --navy-blue: #002e5d;\r\n --brand-orange: #d35400;\r\n --text-dark: #333;\r\n --bg-light: #f4f7f9;\r\n }\r\n\r\n body {\r\n font-family: 'Helvetica Neue', Arial, sans-serif;\r\n line-height: 1.6;\r\n color: var(--text-dark);\r\n background-color: var(--bg-light);\r\n margin: 0;\r\n padding: 0;\r\n }\r\n\r\n .container {\r\n max-width: 900px;\r\n margin: 40px auto;\r\n background: #ffffff;\r\n padding: 50px;\r\n box-shadow: 0 10px 30px rgba(0,0,0,0.1);\r\n border-radius: 8px;\r\n }\r\n\r\n header {\r\n border-bottom: 3px solid var(--navy-blue);\r\n margin-bottom: 40px;\r\n padding-bottom: 20px;\r\n text-align: center;\r\n }\r\n\r\n .top-meta {\r\n font-size: 0.9em;\r\n letter-spacing: 1px;\r\n color: var(--navy-blue);\r\n font-weight: bold;\r\n margin-bottom: 10px;\r\n text-transform: uppercase;\r\n }\r\n\r\n h1 {\r\n color: var(--navy-blue);\r\n font-size: 2.5em;\r\n line-height: 1.2;\r\n margin: 10px 0;\r\n }\r\n\r\n .author-line {\r\n font-style: italic;\r\n color: #666;\r\n margin-bottom: 30px;\r\n }\r\n\r\n h2 {\r\n color: var(--navy-blue);\r\n font-size: 1.8em;\r\n border-left: 5px solid var(--brand-orange);\r\n padding-left: 15px;\r\n margin-top: 40px;\r\n }\r\n\r\n h3 {\r\n color: var(--brand-orange);\r\n font-size: 1.4em;\r\n }\r\n\r\n .highlight-quote {\r\n background: #f0f4f8;\r\n border-left: 5px solid var(--navy-blue);\r\n padding: 25px;\r\n font-size: 1.2em;\r\n font-style: italic;\r\n color: var(--navy-blue);\r\n margin: 30px 0;\r\n }\r\n\r\n table {\r\n width: 100%;\r\n border-collapse: collapse;\r\n margin: 25px 0;\r\n }\r\n\r\n th, td {\r\n border: 1px solid #dee2e6;\r\n padding: 15px;\r\n text-align: left;\r\n }\r\n\r\n th {\r\n background-color: var(--navy-blue);\r\n color: #ffffff;\r\n }\r\n\r\n tr:nth-child(even) { background-color: #f9f9f9; }\r\n\r\n .risk-high { color: #d9534f; font-weight: bold; }\r\n .risk-medium { color: #f0ad4e; font-weight: bold; }\r\n .risk-low { color: #5cb85c; font-weight: bold; }\r\n\r\n .author-bio {\r\n background: #eef2f6;\r\n padding: 30px;\r\n border-radius: 8px;\r\n margin-top: 60px;\r\n border: 1px solid #d1d9e6;\r\n }\r\n\r\n .cta-box {\r\n text-align: center;\r\n background: var(--navy-blue);\r\n color: white;\r\n padding: 40px;\r\n border-radius: 8px;\r\n margin-top: 40px;\r\n }\r\n\r\n .cta-button {\r\n display: inline-block;\r\n background: var(--brand-orange);\r\n color: white;\r\n padding: 15px 30px;\r\n text-decoration: none;\r\n border-radius: 5px;\r\n font-weight: bold;\r\n margin-top: 20px;\r\n }\r\n <\/style>\r\n<\/head>\r\n<body>\r\n\r\n<div class=\"container\">\r\n <header>\r\n <div class=\"top-meta\">PATIENT SAFETY | REGULATORY COMPLIANCE | ISO 10993<\/div>\r\n <h1>Is Your Device File Ready for 2025?<\/h1>\r\n <div class=\"author-line\">By Dr. Priyanka Murawala, PhD, DABT, Founder, Eunoia Compliance | 10 min read<\/div>\r\n <\/header>\r\n\r\n <section>\r\n <div class=\"highlight-quote\">\r\n \u201cThe era of checklist biocompatibility is closing. The era of defensible risk logic has begun.\u201d\r\n <\/div>\r\n <p>The sixth edition of <strong>ISO 10993-1<\/strong>, released in November 2025, redefines the entire framework for biological safety evaluation. It shifts the industry decisively away from prescriptive test selection toward scientifically justified, risk-based reasoning embedded within lifecycle risk management[cite: 94].<\/p>\r\n <\/section>\r\n\r\n <section>\r\n <h2>Key Components of Biocompatibility<\/h2>\r\n <p>Biocompatibility is the ability of a material to perform its intended function without eliciting a harmful local or systemic response in the patient[cite: 10]. Common biological hazards include:<\/p>\r\n <ul>\r\n <li><strong>Cytotoxicity:<\/strong> Cell death caused by toxic leachables[cite: 24].<\/li>\r\n <li><strong>Sensitization:<\/strong> Allergic responses triggered by chemical residues[cite: 25].<\/li>\r\n <li><strong>Genotoxicity:<\/strong> DNA damage that may increase cancer risk over time[cite: 26].<\/li>\r\n <li><strong>Hemocompatibility:<\/strong> Clotting or thrombosis in devices contacting the cardiovascular system[cite: 27].<\/li>\r\n <\/ul>\r\n <\/section>\r\n\r\n <section>\r\n <h2>Major Changes in ISO 10993-1:2025<\/h2>\r\n <table>\r\n <thead>\r\n <tr>\r\n <th>Change<\/th>\r\n <th>Impact<\/th>\r\n <\/tr>\r\n <\/thead>\r\n <tbody>\r\n <tr>\r\n <td>ISO 14971 Alignment<\/td>\r\n <td>Biological evaluation is now fully restructured around risk management.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>Revised Biological Effects<\/td>\r\n <td>\u201cEndpoints\u201d are now \u201cbiological effects,\u201d focusing on clinically relevant outcomes.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>Annex A Refocused<\/td>\r\n <td>Table A.1 is replaced by 4 tissue-specific tables within the main body.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>Local Effects Scope<\/td>\r\n <td>Broadened to recognize non-implantable devices may require tissue contact assessment.<\/td>\r\n <\/tr>\r\n <\/tbody>\r\n <\/table>\r\n <\/section>\r\n\r\n <section>\r\n <h2>Submission Risk Assessment<\/h2>\r\n <p>Inaction creates vulnerabilities during Notified Body review and FDA queries[cite: 109].<\/p>\r\n <table>\r\n <thead>\r\n <tr>\r\n <th>Situation<\/th>\r\n <th>Risk<\/th>\r\n <th>Action Required<\/th>\r\n <\/tr>\r\n <\/thead>\r\n <tbody>\r\n <tr>\r\n <td>Legacy devices (historical testing only)<\/td>\r\n <td class=\"risk-high\">HIGH<\/td>\r\n <td>Full gap assessment + updated scientific justification.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>EU MDR renewal cycle<\/td>\r\n <td class=\"risk-high\">HIGH<\/td>\r\n <td>BEP\/BER update to reflect 2025 structure.<\/td>\r\n <\/tr>\r\n <tr>\r\n <td>New FDA 510(k) submission<\/td>\r\n <td class=\"risk-medium\">MEDIUM<\/td>\r\n <td>Proactive gap analysis advisable.<\/td>\r\n <\/tr>\r\n <\/tbody>\r\n <\/table>\r\n <\/section>\r\n\r\n <div class=\"author-bio\">\r\n <h3>About the Author<\/h3>\r\n <p><strong>Dr. Priyanka Murawala, PhD, DABT<\/strong> is the founder of Eunoia Compliance and a board-certified toxicologist[cite: 114]. With over 10 years of experience, she has supported more than 50 product approvals across FDA, EU MDR, and global markets[cite: 114].<\/p>\r\n <\/div>\r\n\r\n <div class=\"cta-box\">\r\n <h3>Ready to Assess Your Gap?<\/h3>\r\n <p>Don\u2019t wait for a Notified Body query or FDA deficiency letter. Let\u2019s review your device files now and build a clear path to 2025 compliance[cite: 115].<\/p>\r\n <a href=\"mailto:pmurawala@eunoiacompliance.com\" class=\"cta-button\">Schedule a Free Consultation<\/a>\r\n <\/div>\r\n\r\n <footer style=\"text-align: center; font-size: 0.8em; margin-top: 40px; color: #999;\">\r\n \u00a9 2025 Eunoia Compliance \u00b7 Dr. Priyanka Murawala, PhD, DABT \u00b7 www.eunoiacompliance.com [cite: 116]\r\n <\/footer>\r\n<\/div>\r\n\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>ISO 10993-1:2025 Compliance & Biocompatibility – Eunoia Compliance PATIENT SAFETY | REGULATORY COMPLIANCE | ISO 10993 Is Your Device File Ready for 2025? By Dr. Priyanka Murawala, PhD, DABT, Founder, Eunoia Compliance | 10 min read \u201cThe era of checklist biocompatibility is closing. The era of defensible risk logic has begun.\u201d The sixth edition of … <a title=\"Is Your Device File Ready for 2025?\" class=\"read-more\" href=\"https:\/\/eunoiacompliance.com\/index.php\/2026\/05\/09\/is-your-device-file-ready-for-2025\/\" aria-label=\"Read more about Is Your Device File Ready for 2025?\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-756","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts\/756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/comments?post=756"}],"version-history":[{"count":4,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts\/756\/revisions"}],"predecessor-version":[{"id":760,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/posts\/756\/revisions\/760"}],"wp:attachment":[{"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/media?parent=756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/categories?post=756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eunoiacompliance.com\/index.php\/wp-json\/wp\/v2\/tags?post=756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}